Samik Pharm삼익제약
014950 · KOSDAQ · ₩014950 · 삼익제약
₩7,720▲ ₩30 (0.39%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩60B |
| Cost of sales | ₩18B |
| Gross profit | ₩42B |
| Operating income | ₩3.3B |
| Net income | −₩755M |
| Net income to shareholders | −₩789M |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩85B |
| Current assets | ₩57B |
| Cash and equivalents | ₩5.2B |
| Total liabilities | ₩16B |
| Current liabilities | ₩12B |
| Borrowings | ₩2.7B |
| Total equity | ₩69B |
| Shareholders' equity | ₩69B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | ₩2.1B |
| Capital spending | ₩3.4B |
| Free cash flow | −₩1.3B |
| Dividends paid | ₩286M |
Consolidated where available. Amounts in won.
Also known as: Samik Pharm / 삼익제약 / 014950 / KRX:014950
Source: KRX statistical information